Skip to main content
logo
Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
2.980
-0.060 (-1.97%)
Aug 24, 2026, 4:00 PM EDT - Market closed

Elicio Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
781395580--
Market Cap Growth
-59.34%153.09%-31.39%---
Enterprise Value
691345572--
Last Close Price
2.987.965.108.34--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
8.2285.03-4.867.04--
P/TBV Ratio
9.8785.03-7.04--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
1.788.87-2.300.610.84-2.88
Net Debt / Equity Ratio
-1.18-2.48-0.74-0.530.15-0.61
Net Debt / EBITDA Ratio
0.250.11-0.190.17-0.06-0.10
Net Debt / FCF Ratio
0.250.11-0.230.18-0.06-0.10
Quick Ratio
2.552.291.531.320.900.49
Current Ratio
2.772.381.801.681.560.55
Return on Equity (ROE)
-774.56%--170157.38%-346.95%-1170.93%-430.76%
Return on Assets (ROA)
-77.88%-87.24%-101.64%-89.70%-79.16%-92.36%
Return on Capital Employed (ROCE)
-171.40%-212.40%-270.10%-205.50%-150.20%626.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-48.32%-28.45%-94.42%-43.93%--
FCF Yield
-48.15%-26.58%-67.60%-40.89%--
Buyback Yield / Dilution
-23.82%-25.48%-141.35%-1500.08%97.93%-42.39%
SEC Filings: 10-K · 10-Q